Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1 1

Status

Completed 12Terminated 6Active not recruiting 4Recruiting 2Withdrawn 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 3Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Rectal Neoplasms 11Glioblastoma 10Breast Neoplasms 10Lung Neoplasms 9Head and Neck Neoplasms 8Neoplasms 6Neoplasm Metastasis 6Brain Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Prostatic Neoplasms 5Leukemia 4Gliosarcoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Melanoma 3Leukemia, Myeloid, Acute 3Carcinoma, Squamous Cell 3Carcinoma, Renal Cell 3Carcinoma, Merkel Cell 3Adenocarcinoma Of Esophagus 3Xerostomia 2Waldenstrom Macroglobulinemia 2Small Cell Lung Carcinoma 2Recurrence 2Myelodysplastic Syndromes 2Mycosis Fungoides 2

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Radiation × Clear all
NCT03419403 2021-04-14

UNITE Study: Understanding New Interventions With GBM ThErapy

AbbVie

Phase 3 Terminated
40 enrolled 16 charts
CNS

Glioblastoma, Neoplasms

NCT02714530 2021-03-30

ThoRaT

Oslo University Hospital

Phase 2 Terminated
118 enrolled
Tumor-Agnostic

Neoplasms

NCT02500173 2021-03-09

Analysis of Effects and Side Effects in Patients Undergoing Radiation Therapy

Kantonsspital Graubuenden

Terminated
1,800 enrolled
Tumor-Agnostic

Neoplasms

NCT01518621 2019-03-13

RadEr

Oslo University Hospital

Phase 2 Terminated
25 enrolled
Tumor-Agnostic

Neoplasms

NCT01642732 2017-05-30

Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer

University of Michigan Rogel Cancer Center

Phase 1 Terminated
1 enrolled 2 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00250835 2015-09-01

Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer

New Mexico Cancer Research Alliance

Phase 2 Terminated
38 enrolled 11 charts
Gastrointestinal

Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡